India  
 
NewsR.in

Phase 1 of COVID-19 vaccine trial to be done on people aged between 18-55 yrs: AIIMS Director

Video Credit: ANI - Duration: 02:06s - Published
Phase 1 of COVID-19 vaccine trial to be done on people aged between 18-55 yrs: AIIMS Director

Phase 1 of COVID-19 vaccine trial to be done on people aged between 18-55 yrs: AIIMS Director

While addressing a press conference in the national capital on July 20, the director of All India Institute of Medical Sciences (AIIMS), Professor Randeep Guleria spoke on vaccine trail amid coronavirus pandemic.

He said, "Phase 1 of vaccine trial will be done on healthy people aged between 18-55 years who have no co-morbidity." "A total of 1,125 samples have been collected of which 375 will be studied in first phase and in second phase 750 people will be recruited between 12-65 years," AIIMS Director added.


You Might Like

Related news from verified sources

Delhi: 1,800 call to volunteer for Covid-19 vaccine trial at AIIMS, only 100 required

The first phase of the trial for Covaxin, India’s indigenous Covid-19 vaccine, began in AIIMS on...
IndiaTimes - Published


Related videos from verified sources

Watch: Health Ministry gives updates on Covid cases, vaccines & herd immunity [Video]

Watch: Health Ministry gives updates on Covid cases, vaccines & herd immunity

The health ministry in its briefing on Covid-19 situation said that over 1 million people have recovered from Covid infection in the country. Addressing the media, Secretary in the Health Ministry..

Credit: HT Digital Content     Duration: 08:50Published
Covid: First part of phase-1 Covaxin human trial completed at PGI Rohtak [Video]

Covid: First part of phase-1 Covaxin human trial completed at PGI Rohtak

The first part of phase-1 of Covaxin human trial completed on Saturday. The trial was conducted at Post-Graduate Institute (PGI) of Medical Sciences, Rohtak, said Dr Savita Verma, principal..

Credit: HT Digital Content     Duration: 02:37Published
Part 1 of phase-1 Covaxin trial shows encouraging results: Rohtak PGI Doctor [Video]

Part 1 of phase-1 Covaxin trial shows encouraging results: Rohtak PGI Doctor

As the world is scrambling to develop a COVID-19 vaccine, Principal Investigator of vaccine trial team at Rohtak PGI Doctor Savita Verma informed that part 1 of phase-1 of Covaxin trial is completed..

Credit: ANI     Duration: 01:46Published